title: Does evidence-based medicine really reduce costs?
abstract: The high cost of oncology is gaining a lot of attention these days. With cancer care accounting for ten percent of healthcare costs, payers are hungry to find ways to be more frugal. As oncologists, it is in our best interest, as well as the best interest of our patients, to take a proactive, leadership role in finding solutions that sustain our ability to deliver high-quality care.
authors.affiliation: New York Oncology Hematology and Albany Cancer Center, Albany, New York, USA.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Kolodziej
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine; D017048:Health Care Costs / Q000639:trends*; D006801:Humans; D019458:Insurance Coverage; D009369:Neoplasms / Q000175:diagnosis / Q000191:economics* / Q000628:therapy; D010818:Practice Patterns, Physicians'
chemical_list: D000970:Antineoplastic Agents